BiotechTube
Home/Imunexus Therapeutics/Philippa Lewis
PL

Philippa Lewis

Executive Director and Chairperson

Imunexus Therapeutics

Therapeutic Areas

OncologyNeurologyRare Disease

Imunexus Therapeutics Pipeline

DrugIndicationPhase
IMX101Small Cell Lung CancerPreclinical
IMX113Rare Pediatric DiseasePreclinical
IMX39Multiple SclerosisPreclinical

Leadership Team at Imunexus Therapeutics

DB
Don Brumley
Non‑Executive Director
DG
Dr George Kopsidas
Chief Scientific Officer and Founder
CE
Chris Elliot
Chief Financial Officer and Company Secretary
View full Imunexus Therapeutics profile